Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jeffrey Crowley

Jeffrey J Crowley MD FAAD

Dermatologist and Clinical Trial Director, Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, CA

Disclosures

 Disclosures:

          -Consultant, speaker, investigator:  Abbvie, Amgen, Celgene, Lilly, Novartis

          -Investigator, consultant:  Janssen, Sun, Regeneron

          -Investigator:  Merck, Pfizer, Sandoz

Recent Contributions to PracticeUpdate:

  1. Comparison of the Effectiveness of Adalimumab, Etanercept, and Ustekinumab in Psoriasis Patients

Most Read This Week

Recently Updated